Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.03) by 33.33 percent. The company reported quarterly sales of $27.937 million which missed the analyst consensus estimate of $29.300 million by 4.65 percent. This is a 11.66 percent increase over sales of $25.019 million the same period last year.